Cash and Short Term Investments (Annual) Chart

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2005. Start Trial.
Date Value
December 31, 2025 59.89M
December 31, 2024 44.15M
December 31, 2023 52.90M
December 31, 2022 33.50M
December 31, 2021 45.11M
December 31, 2020 27.51M
December 31, 2019 7.878M
December 31, 2018 16.82M
December 31, 2017 1.353M
December 31, 2016 1.736M
December 31, 2015 0.1655M
Date Value
December 31, 2014 0.2042M
December 31, 2013 2.527M
December 31, 2012 2.338M
December 31, 2011 2.659M
December 31, 2010 2.855M
December 31, 2009 0.6288M
December 31, 2008 2.433M
December 31, 2007 3.514M
December 31, 2006 0.27M
December 31, 2005 0.2732M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 1.193B
Nektar Therapeutics 245.75M
Fortress Biotech, Inc. 79.38M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B